Clinical Trial Update: Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal

View source ↗

Summary

Clinical trial update for an ancillary FABP2 proposal in Type 2 Diabetes Mellitus; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED